These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 11352248

  • 1. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.
    Stone JH, Uhlfelder ML, Hellmann DB, Crook S, Bedocs NM, Hoffman GS.
    Arthritis Rheum; 2001 May; 44(5):1149-54. PubMed ID: 11352248
    [Abstract] [Full Text] [Related]

  • 2. Etanercept plus standard therapy for Wegener's granulomatosis.
    Wegener's Granulomatosis Etanercept Trial (WGET) Research Group.
    N Engl J Med; 2005 Jan 27; 352(4):351-61. PubMed ID: 15673801
    [Abstract] [Full Text] [Related]

  • 3. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
    Seo P, Min YI, Holbrook JT, Hoffman GS, Merkel PA, Spiera R, Davis JC, Ytterberg SR, St Clair EW, McCune WJ, Specks U, Allen NB, Luqmani RA, Stone JH, WGET Research Group.
    Arthritis Rheum; 2005 Jul 27; 52(7):2168-78. PubMed ID: 15986348
    [Abstract] [Full Text] [Related]

  • 4. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
    Stone JH, Holbrook JT, Marriott MA, Tibbs AK, Sejismundo LP, Min YI, Specks U, Merkel PA, Spiera R, Davis JC, St Clair EW, McCune WJ, Ytterberg SR, Allen NB, Hoffman GS, Wegener's Granulomatosis Etanercept Trial Research Group.
    Arthritis Rheum; 2006 May 27; 54(5):1608-18. PubMed ID: 16646004
    [Abstract] [Full Text] [Related]

  • 5. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.
    Stone JH, Wegener's Granulomatosis Etanercept Trial Research Group.
    Arthritis Rheum; 2003 Aug 27; 48(8):2299-309. PubMed ID: 12905485
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
    Weinblatt ME, Schiff MH, Ruderman EM, Bingham CO, Li J, Louie J, Furst DE.
    Arthritis Rheum; 2008 Jul 27; 58(7):1921-30. PubMed ID: 18576334
    [Abstract] [Full Text] [Related]

  • 7. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.
    Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Lange M, Finck BK, Burge DJ, Pediatric Rheumatology Collaborative Study Group.
    Arthritis Rheum; 2003 Jan 27; 48(1):218-26. PubMed ID: 12528122
    [Abstract] [Full Text] [Related]

  • 8. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
    Genovese MC, Cohen S, Moreland L, Lium D, Robbins S, Newmark R, Bekker P, 20000223 Study Group.
    Arthritis Rheum; 2004 May 27; 50(5):1412-9. PubMed ID: 15146410
    [Abstract] [Full Text] [Related]

  • 9. Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
    Kimura Y, Pinho P, Walco G, Higgins G, Hummell D, Szer I, Henrickson M, Watcher S, Reiff A.
    J Rheumatol; 2005 May 27; 32(5):935-42. PubMed ID: 15868633
    [Abstract] [Full Text] [Related]

  • 10. High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate.
    Reinhold-Keller E, Fink CO, Herlyn K, Gross WL, De Groot K.
    Arthritis Rheum; 2002 Jun 15; 47(3):326-32. PubMed ID: 12115164
    [Abstract] [Full Text] [Related]

  • 11. Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis.
    Moreland LW, Cohen SB, Baumgartner SW, Tindall EA, Bulpitt K, Martin R, Weinblatt M, Taborn J, Weaver A, Burge DJ, Schiff MH.
    J Rheumatol; 2001 Jun 15; 28(6):1238-44. PubMed ID: 11409115
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Martin Mola E, Pedersen R, Robertson D, Chang D, Koenig A, Freundlich B, Etanercept Study Investigators.
    Ann Rheum Dis; 2009 Jul 15; 68(7):1113-8. PubMed ID: 18718986
    [Abstract] [Full Text] [Related]

  • 13. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators.
    Ann Rheum Dis; 2008 Feb 15; 67(2):182-8. PubMed ID: 17728331
    [Abstract] [Full Text] [Related]

  • 14. Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results.
    Fleischmann RM, Baumgartner SW, Tindall EA, Weaver AL, Moreland LW, Schiff MH, Martin RW, Spencer-Green GT.
    J Rheumatol; 2003 Apr 15; 30(4):691-6. PubMed ID: 12672185
    [Abstract] [Full Text] [Related]

  • 15. Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice.
    Stone JH, Tun W, Hellman DB.
    J Rheumatol; 1999 May 15; 26(5):1134-9. PubMed ID: 10332980
    [Abstract] [Full Text] [Related]

  • 16. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
    Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puéchal X, Vinzio S, Cohen P, Mouthon L, Cordier JF, Guillevin L, French Vasculitis Study Group.
    N Engl J Med; 2008 Dec 25; 359(26):2790-803. PubMed ID: 19109574
    [Abstract] [Full Text] [Related]

  • 17. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
    Brandt J, Khariouzov A, Listing J, Haibel H, Sörensen H, Grassnickel L, Rudwaleit M, Sieper J, Braun J.
    Arthritis Rheum; 2003 Jun 25; 48(6):1667-75. PubMed ID: 12794835
    [Abstract] [Full Text] [Related]

  • 18. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
    Kremer JM, Weinblatt ME, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Jackson CG, Atkins KM, Feng A, Burge DJ.
    Arthritis Rheum; 2003 Jun 25; 48(6):1493-9. PubMed ID: 12794815
    [Abstract] [Full Text] [Related]

  • 19. A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).
    Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, Specks U, Allen NB, Davis JC, Spiera RF, Calabrese LH, Wigley FM, Maiden N, Valente RM, Niles JL, Fye KH, McCune JW, St Clair EW, Luqmani RA, International Network for the Study of the Systemic Vasculitides (INSSYS).
    Arthritis Rheum; 2001 Apr 25; 44(4):912-20. PubMed ID: 11318006
    [Abstract] [Full Text] [Related]

  • 20. Maintenance of remission with leflunomide in Wegener's granulomatosis.
    Metzler C, Fink C, Lamprecht P, Gross WL, Reinhold-Keller E.
    Rheumatology (Oxford); 2004 Mar 25; 43(3):315-20. PubMed ID: 14963200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.